These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4573419)

  • 1. The clinical pharmacology of imipramine. Implications for therapeutics.
    Glassman AH; Perel JM
    Arch Gen Psychiatry; 1973 May; 28(5):649-53. PubMed ID: 4573419
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
    Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of imipramine and desmethylimipramine during therapy.
    Moody JP; Tait AC; Todrick A
    Br J Psychiatry; 1967 Feb; 113(495):183-93. PubMed ID: 6032479
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation between plasma and cerebrospinal levels of imipramine.
    Sathananthan GL; Gershon S; Almeida M; Spector N; Spector S
    Arch Gen Psychiatry; 1976 Sep; 33(9):1109-10. PubMed ID: 962493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of imipramine and desipramine in human breast milk.
    Sovner R; Orsulak PJ
    Am J Psychiatry; 1979 Apr; 136(4A):451-2. PubMed ID: 426114
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipramine and chlorpromazine in hepatic microsomal systems.
    Perel JM; O'Brien L; Black NB; Bellward GD; Dayton PG
    Adv Biochem Psychopharmacol; 1974; 9(0):201-12. PubMed ID: 4836204
    [No Abstract]   [Full Text] [Related]  

  • 10. The kinetics of imipramine-N-oxide in man.
    Nagy A; Hansen T
    Acta Pharmacol Toxicol (Copenh); 1978 Jan; 42(1):58-67. PubMed ID: 579712
    [No Abstract]   [Full Text] [Related]  

  • 11. The route of administration of imipramine as a factor affecting formation of its metabolite desipramine.
    Daniel W; Adamus A; Melzacka M; Szymura J
    J Pharm Pharmacol; 1982 Oct; 34(10):678-80. PubMed ID: 6128396
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic interaction of disulfiram and antidepressants.
    Ciraulo DA; Barnhill J; Boxenbaum H
    Am J Psychiatry; 1985 Nov; 142(11):1373-4. PubMed ID: 4061700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats.
    Nagy A
    J Pharm Pharmacol; 1977 Feb; 29(2):104-7. PubMed ID: 15053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma tricyclic levels with therapeutic doses of imipramine.
    Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB
    Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential clinical use for methylphenidate with tricyclic antidepressants.
    Wharton RN; Perel JM; Dayton PG; Malitz S
    Am J Psychiatry; 1971 Jun; 127(12):1619-25. PubMed ID: 4998422
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of hypnotics on imipramine treatment.
    Ballinger BR; Presly A; Reid AH; Stevenson IH
    Psychopharmacologia; 1974; 39(3):267-74. PubMed ID: 4427993
    [No Abstract]   [Full Text] [Related]  

  • 18. The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.
    Skjelbo E; Gram LF; Brøsen K
    Br J Clin Pharmacol; 1993 Mar; 35(3):331-4. PubMed ID: 8471415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of imipramine in depressed patients.
    Perel JM; Hurwic MJ; Kanzler MB
    Psychopharmacol Bull; 1975 Oct; 11(4):16-8. PubMed ID: 1105635
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of imipramine, desmethylimipramine, nortriptyline and 1-naphthol with microsomal preparations.
    von Bahr C; Orrenius S; Sjöqvist F
    Chem Biol Interact; 1971 Aug; 3(4):243-4. PubMed ID: 5132990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.